Advertisement
Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Overview

Explore Madrigal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MDGL●NASDAQ
HealthcareBiotechnology
$492.83
$4.68(0.96%)
U.S. Market opens in 16h 8m
Advertisement

Madrigal Pharmaceuticals, Inc. (MDGL)

Meyka AI Score

Z

Key Financials

Market Cap11.4B
P/E Ratio-45.11
EPS (TTM)$-13.50
ROE-0.50%
Fundamental Analysis

AI Price Forecasts

1 Month$465.73
3 Months$486.37
1 Year Target$519.32

MDGL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Madrigal Pharmaceuticals, Inc. (MDGL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $519.32.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -45.11 and a market capitalization of 11.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.96%
5-Day Change
-4.22%
1-Month Change
-4.98%
3-Month Change
13.35%
6-Month Change
-15.93%
Year-to-Date (YTD) Change
-15.37%
1-Year Change
76.44%
3-Year Change
84.91%
5-Year Change
387.56%
All-Time (Max) Change
54.90%

Contact Information

https://www.madrigalpharma.com
267 824 2827
Four Tower Bridge, West Conshohocken, PA, 19428

Company Facts

528 Employees
IPO DateFeb 6, 2007
CountryUS
Actively Trading

Frequently Asked Questions